Last reviewed · How we verify
NCT04868201
A Self-guided App-Based Virtual Reality Cognitive Behavior Therapy for Anxiety Disorder in Children
NA trial testing 0-anxiety in Anxiety Disorders in 230 participants. Status unknown.
1 February 2023
Quick facts
| Lead sponsor | Universidade Federal do Rio de Janeiro |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 230 |
| Start date | 1 August 2021 |
| Primary completion | 1 February 2023 |
| Estimated completion | 1 February 2023 |
Drugs / interventions tested
- 0-anxiety
Conditions studied
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
Universidade Federal do Rio de Janeiro — full company profile →
Who can join
Adults 8 to 12, any sex, with Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To examine the efficacy of a fully self-guided app-based virtual reality cognitive behavior therapy (VR CBT) using low-cost (cardboard) virtual reality goggles compared with a wait-list control group and to determine its user friendliness. We hypothesize that children with GAD enrolled in the self-guided app will present lower scores of anxiety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04868201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders
Currently open trials in the same condition.
- NCT07340281 — Biomarkers for Exercise · NA · recruiting
- NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
- NCT07316374 — AI Chatbots for Anxiety Mental Health Literacy · NA · active not recruiting
- NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
- NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting
Other Universidade Federal do Rio de Janeiro trials
Trials by the same sponsor.
- NCT07584564 — Application of the Concept of Proprioceptive Neuromuscular Facilitation in Trunk Control in Patients Admitted to the ICU · NA · not yet recruiting
- NCT07062497 — Clonidine in Ultrasound-guided Rectus Sheath Block for Outpatient Umbilical Hernioplasty · Phase 2, PHASE3 · recruiting
- NCT07191743 — Functional Assessment in Critically Ill Patients · recruiting
- NCT06733714 — Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in · NA · recruiting
- NCT07391943 — Self-Guided CBT Mobile App for Treatment-Resistant Panic Disorder (CBT) Cognitive Behavioral Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04868201 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal do Rio de Janeiro
- Last refreshed: 30 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04868201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing